Lloyd’s insurers Beazley and Chaucer back IVF insurance start-up Gaia
Lloyd’s insurers Beazley and Chaucer have partnered with London-based insurtech Gaia to offer a new solution for individuals undertaking IVF treatment.
The health-focussed Lloyd’s Lab alumnus has been working with Beazley and Chaucer to design a new underwriting approach and has been appointed as a Lloyd’s Coverholder.
The product, led by Beazley with further support from Chaucer and Atrium, covers eligible Gaia members for their treatment fees in the event their IVF treatment programme isn’t successful. Policyholders are also offered a fund that can be used to pay for counselling costs.
Gaia leverages millions of data points to predict personalised success rates for IVF treatment with the aim of providing transparency and greater element of predictability into the fertility process.
George Beattie (pictured), head of incubation underwriting at Beazley, said: “The Gaia proposition is unique because it represents the embedded digital distribution of a completely new type of insurance product. The Gaia solution also caters for a market that is set to grow exponentially in the coming years as fertility levels continue to decline globally. For many, accessing IVF treatment is fraught with confusion, a requirement to have significant savings to start treatment and a lack of transparency around options and outcomes.
“We are delighted to have a partner that is aiming to change the status quo and to help people realise their dreams. Although our insurance product cannot mitigate the personal implications of an IVF program not being successful, our aim is to play a positive role by at least removing the financial concern of having to pay for treatment fees following failure and by helping individuals get the counselling support they need.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
